Literature DB >> 33320417

The Stanford Integrated Psychosocial Assessment for Transplant Is Associated With Outcomes Before and After Liver Transplantation.

Sasha Deutsch-Link1, Ethan M Weinberg2, Therese Bittermann2, Mackenzie McDougal3, Aniket Dhariwal4, Lauren S Jones5, Robert M Weinrieb6, Arpita G Banerjee6, Senayish Addis2, Marina Serper2,7.   

Abstract

The Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) is a standardized psychosocial evaluation tool used in liver transplantation (LT) evaluation. We assessed the impact of the SIPAT score and subdomains on transplant waitlisting decisions and post-LT outcomes including immunosuppression (IS) nonadherence, biopsy-proven rejection, andmortality/graft failure. We conducted a single-center observational cohort study of 1430 patients evaluated for LT. Patients were divided in 2 groups based on a SIPAT cutoff score of <21 or ≥21 (higher SIPAT scores indicate higher psychosocial risk). Regression models assessed relationships between total SIPAT score and domain scores and waitlisting decisions, IS nonadherence, allograft rejection, and death/graft failure. Elevated total SIPAT and SIPAT domain scores were associated not being added to the waitlist (total SIPAT core ≥21 adjusted odds ratio [aOR], 1.78 [95% confidence interval, CI, 1.36-2.33]; readiness score ≥5 aOR, 2.01 [95% CI, 1.36-2.76]; social support score ≥4aOR, 1.50 [95% CI, 1.15-1.94]; psychopathology score ≥7 aOR, 1.45 [95% CI, 1.07-1.94]; lifestyle/substance abuse score ≥12 aOR, 1.72 [95%CI, 1.23-2.39]) and were more likely to experience IS nonadherence as measured by the tacrolimus coefficient of variation (CoV) (total SIPAT score ≥21 aOR, 2.92 [95% CI, 1.69-5.03]; readiness score ≥5 aOR, 3.26 [95% CI, 1.63-6.52]; psychopathology score ≥7 aOR, 1.88 [95% CI, 1.00-3.50]; lifestyle substance abuse score ≥12 aOR, 3.03 [95% CI, 1.56-5.86]). SIPAT readinessscore ≥5 was associated with biopsy-proven allograft rejection (aOR, 2.66; 95% CI, 1.20-5.91). The SIPAT score was independently associated with LT listing decisions and IS nonadherence, and the readiness domain was associated with the risk of allograft rejection. These findings offer insights into higher risk recipients who require additional support before and aftertransplantation.
Copyright © 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2021        PMID: 33320417      PMCID: PMC9531321          DOI: 10.1002/lt.25975

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   6.112


  36 in total

Review 1.  To transplant or not? The importance of psychosocial and behavioural factors before lung transplantation.

Authors:  F Dobbels; G Verleden; L Dupont; J Vanhaecke; S De Geest
Journal:  Chron Respir Dis       Date:  2006       Impact factor: 2.444

2.  Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation.

Authors:  Sasha Deutsch-Link; Robert M Weinrieb; Lauren S Jones; Steven F Solga; Ethan M Weinberg; Marina Serper
Journal:  Dig Dis Sci       Date:  2019-11-09       Impact factor: 3.199

Review 3.  The Psychosocial Treadmill: the Road to Improving High-risk Behavior in Advanced Therapy Candidates.

Authors:  Laura Newman
Journal:  Curr Heart Fail Rep       Date:  2018-04

4.  Measures of psychosocial factors that may influence help-seeking behaviour in cancer: A systematic review of psychometric properties.

Authors:  Sonja Kummer; Fiona M Walter; Joseph Chilcot; Suzanne Scott
Journal:  J Health Psychol       Date:  2017-05-16

5.  Effect of the iChoose Kidney decision aid in improving knowledge about treatment options among transplant candidates: A randomized controlled trial.

Authors:  Rachel E Patzer; Laura McPherson; Mohua Basu; Sumit Mohan; Michael Wolf; Mariana Chiles; Allison Russell; Jennifer C Gander; John J Friedewald; Daniela Ladner; Christian P Larsen; Thomas Pearson; Stephen Pastan
Journal:  Am J Transplant       Date:  2018-03-26       Impact factor: 8.086

6.  Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications.

Authors:  M A Chisholm; L L Mulloy; M Jagadeesan; J T DiPiro
Journal:  Clin Transplant       Date:  2001-10       Impact factor: 2.863

7.  Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services.

Authors:  Laurie Sylla; R Douglas Bruce; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2007-05-10

8.  Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring.

Authors:  Anja Klein; Gerd Otto; Irene Krämer
Journal:  Transplantation       Date:  2009-03-27       Impact factor: 4.939

Review 9.  Efficacy of interventions for adherence to the immunosuppressive therapy in kidney transplant recipients: a meta-analysis and systematic review.

Authors:  Yichen Zhu; Yifan Zhou; Lei Zhang; Jian Zhang; Jun Lin
Journal:  J Investig Med       Date:  2017-05-08       Impact factor: 2.895

10.  Low Health Literacy Is Associated With Frailty and Reduced Likelihood of Liver Transplant Listing: A Prospective Cohort Study.

Authors:  Therese Bittermann; Kristen Dwinnells; Sakshum Chadha; Michael S Wolf; Kim M Olthoff; Marina Serper
Journal:  Liver Transpl       Date:  2020-10-07       Impact factor: 5.799

View more
  1 in total

Review 1.  Covid-19 and alcohol associated liver disease.

Authors:  Sasha Deutsch-Link; Brenda Curtis; Ashwani K Singal
Journal:  Dig Liver Dis       Date:  2022-08-03       Impact factor: 5.165

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.